Shandong Oriental Ocean's Avico unit obtains medical device certificate

Shandong Oriental Ocean Sci-Tech Co., Ltd. announced that its wholly-owned subsidiary, Avico Biotechnology Co., Ltd., recently obtained a medical device registration certificate from the Shandong Provincial Drug Administration. The certificate is for the "Full-range C-reactive protein (hSCRP+CRP) measurement reagent kit (fluorescent immunoassay method)." It is valid from October 26, 2025, to October 25, 2030.

The kit is intended for the quantitative detection of C-reactive protein in human serum, plasma, whole blood, and peripheral blood samples. This approval enriches Avico Biotechnology's product offerings in the clinical detection field.

However, the company cautions investors that the impact on its performance this year is expected to be minimal. The product has not yet entered production, and its actual sales performance will be influenced by market expansion efforts and demand. Consequently, the future impact on the company's financial results remains uncertain. Investors are advised to exercise caution due to these risks.